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Abstract
Background: Brevican is a member of the lectican family of aggregating extracellular matrix (ECM)
proteoglycans that bear chondroitin sulfate (CS) chains. It is highly expressed in the central nervous
system (CNS) and is thought to stabilize synapses and inhibit neural plasticity and as such, neuritic
or synaptic remodeling would be less likely to occur in regions with intact and abundant, lectican-
containing, ECM complexes. Neural plasticity may occur more readily when these ECM complexes
are broken down by endogenous proteases, the ADAMTSs (adisintegrin and metalloproteinase
with thrombospondin motifs), that selectively cleave the lecticans. The purpose of these
experiments was to determine whether the production of brevican or the ADAMTS-cleaved
fragments of brevican were altered after deafferentation and reinnervation of the dentate gyrus via
entorhinal cortex lesion (ECL).
Results: In the C57Bl6J mouse, synaptic density in the molecular layer of the dentate gyrus, as
measured by synaptophysin levels in ELISA, was significantly attenuated 2 days (nearly 50% of
contralateral) and 7 days after lesion and returned to levels not different from the contralateral
region at 30 days. Immunoreactive brevican in immunoblot was elevated 2 days after lesion,
whereas there was a significant increase in the proteolytic product at 7, but not 30 days post-lesion.
ADAMTS activity, estimated using the ratio of the specific ADAMTS-derived brevican fragment and
intact brevican levels was increased at 7 days, but was not different from the contralateral side at
2 or 30 days after deafferentation.
Conclusion: These findings indicate that ADAMTS activity in the dentate outer molecular layer
(OML) is elevated during the initial synaptic reinnervation period (7 days after lesion). Therefore,
proteolytic processing of brevican appears to be a significant extracellular event in the remodeling
of the dentate after EC lesion, and may modulate the process of sprouting and/or synaptogenesis.
Background
Neurons of the entorhinal cortex (EC) send unidirec-
tional, afferent projections to the hippocampus, where
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terminals synapse on granule cell dendrites in the outer
molecular layer (OML) of the dentate gyrus [1]. Interrup-
tion of entorhinal input to the dentate gyrus, by chemical
lesion or severing the afferent fibers, causes anterograde
degeneration of the axon terminals and stimulates sprout-
ing of viable fibers from this and other neuronal circuits
[2-5]. The entorhinal cortex lesion (ECL) has been used as
a model of neural plasticity for more than three decades
[6]. To identify and innervate a target after injury or dur-
ing development, growing neuron terminals must traverse
through a complex extracellular milieu that consists of
soluble factors, cell surface adhesive ligands and an extra-
cellular matrix (ECM) along the way toward its target. The
growing terminal samples this milieu, and appropriate
protein-protein binding and activation regulates the direc-
tion and extent of growth, terminal sprouting, and likely
synaptogenesis. For example, certain ECM molecules such
as laminin are permissive toward neurite outgrowth,
whereas others, such as the highly negatively charged, pro-
teoglycans (PGs) substituted with chondroitin sulfate
(CS) (ie. versican, neurocan, aggrecan and brevican, in
general, lecticans), inhibit neurite outgrowth on permis-
sive substrates [7-9]. Interestingly, the expression of sev-
eral lecticans, including brevican is markedly up-regulated
during the neural plasticity response that occurs following
ECL [10].
The lectican PGs are the most abundant ECM molecules in
the adult, uninjured central nervous system (CNS) and of
these brevican is the most highly expressed [11,12]. Brev-
ican and other lecticans are found in perineuronal nets
and throughout the neuropil and are components of ECM
aggregate complexes that are thought to stabilize synapses
in neural networks and inhibit neurite outgrowth [13,14].
Most evidence suggests that the CS component in these
complexes provides the inhibitory signal toward neurite
outgrowth, although the protein core plays a role as well
[8,15]. However, proteolytic cleavage of the brevican core
protein may "loosen" the aggregated complexes and
change the extracellular environment to one that is more
permissive for neural plasticity to occur [14,16,17]. A sig-
nificant proportion of brevican in the adult CNS exists as
a fragment formed by proteolytic cleavage of the protein
core, suggesting that this mechanism may play a role in
experience-dependent and other forms of neural plasticity
in the uninjured, adult. In addition, in disorders such as
Alzheimer's disease, alterations in the ECM may be related
to diminished synaptic plasticity and therefore play a role
in cognitive dysfunction.
The metalloproteinases responsible for cleavage of lecti-
can core proteins and the generation of fragments of
aggrecan, brevican, and versican have been cloned and
belong to a family of proteins, termed the ADAMTSs
(adisintegrin and metalloproteinase with thrombospon-
din motifs), that include glutamyl endopeptidases.
ADAMTS1 and ADAMTS4 are prominently expressed in
rat brain [16] and cleave the 145 kD intact core protein of
brevican into a 55 kD N-terminal, and an 80 kD C-termi-
nal fragment [18,19] (see Fig. 2). The ADAMTS-derived 55
kD fragment may be distinguished from total cleaved frag-
ment (cleaved by other proteinases) using a neoepitope
antibody raised against the distinctive C-terminal
sequence (EAMESE, murine sequence) of the N-terminal,
55 kD fragment (see Fig. 2, "C") that is generated by
glutamyl endopeptidase cleavage. Using this antibody, in
vivo ADAMTS activity may be estimated by expressing the
amount of ADAMTS-derived brevican fragment as a pro-
portion of total intact brevican.
Others have demonstrated changes in the levels and activ-
ity of matrix metalloproteinases (MMPs) in the deaffer-
ented neuropil after various lesions, however in these
experiments, the substrate proteolytically processed by
the MMPs was not identified [20,21]. Nonetheless,
changes in structure and function that were associated
with lesion-induced sprouting were reversed by MMP
inhibitors [22]. Lesions produced by systemic injection of
kainic acid produce wide-spread neuronal degeneration
in the CNS, including the EC and stimulate expression of
the MMPs and the ADAMTSs [16,23]. In response to this
lesion, the abundance of the neoepitope fragment gener-
ated by ADAMTS-cleavage of brevican was markedly
elevated in the OML of the dentate gyrus. This increase
was preceded by elevated ADAMTS1 and ADAMTS4
mRNA expression in dentate granule neurons [16].
Although these results suggest that proteolytic processing
of brevican appears to be a significant extracellular event
in the remodeling of the dentate after ECL, because of the
widespread neuronal death, it was difficult to associate
these two particular endpoints as individual, yet associ-
ated events involved in neural plasticity. Thus, we decided
to employ the classical ECL model in the C57Bl6 mouse,
thereby discretely disrupting synaptic innervation of the
molecular layer of the dentate gyrus. Our intention was to
observe any altered expression of brevican and the
ADAMTSs that may be associated with reinnervation of
the injured area 2, 7 and 30 days after lesion.
Results
Expression of ADAMTS-derived, brevican fragment
Brevican is an abundantly expressed PG in the CNS that is
secreted from astrocytes and neurons as a 145 kD core
protein that bears up to three, covalently-linked, CS
chains (Fig. 2A). It is also is secreted as a 145 kD core pro-
tein without CS chains (Fig. 2B). When cleaved by extra-
cellular glutamyl endopeptidases, the ADAMTSs, a 55 kD
N-terminal fragment is formed that contains the unique
C-terminal epitope EAMESE (Fig. 2C). Each of these iso-
forms of brevican was expressed in numerous regions ofBMC Neuroscience 2005, 6:52 http://www.biomedcentral.com/1471-2202/6/52
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Schematic representation of the micro-dissection of dentate gyrus and entorhinal cortex Figure 1
Schematic representation of the micro-dissection of dentate gyrus and entorhinal cortex: This procedure was 
developed to isolate dentate gyrus and entorhinal cortex tissue from different rostral-caudal slabs in fresh-frozen mouse brain. 
A: Coronal section of mouse brain showing bore holes left from blunt-ended, 22 gauge needle punch (green) in the ipsilateral 
and contralateral dentate gyrus. B: Coronal section of mouse brain (2 mm caudal from section in "A") showing bore holes left 
from blunt-ended, 18 gauge needle punch (green) in the ipsilateral and contralateral entorhinal cortex. C: Sagittal view of 2 mm 
slices used for the collection of dentate gyrus (A) and entorhinal cortex (B). Diagrams adapted from 'The Mouse Brain' [46].
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the CNS. Figure 3A shows a brevican immunoblot of sev-
eral brain regions from an untreated C57Bl6 mouse. The
>145 kD (brevican core plus CS) intact isoform, the 145
kD (brevican core) intact core protein and the generalized
55 kD N-terminal fragment were easily differentiated
from one another on Western blot (Fig. 3A) using an anti-
body that recognizes an epitope in the N-terminal globu-
lar domain (Fig. 2). In the mouse, all isoforms of brevican
appeared to be more abundant in brain stem and cerebel-
lum compared to other regions that were measured. Panel
B shows a blot with the same extracts and probed using
the anti-neoepitope EAMESE antibody. This antibody rec-
ognized the ADAMTS-derived, C-terminally truncated, 55
kD fragment with the novel C-terminal epitope EAMESE
and did not recognize any of the intact, core brevican
proteins (Fig. 3B). Thus, given the ability to quantitate the
ADAMTS-derived brevican fragment and its intact sub-
strates using immunoblot, regional in vivo ADAMTS activ-
ity may be estimated.
Deafferentation and neural plasticity in the dentate gyrus
To validate a complete deafferentation of this synapse of
the perforant path, from the EC to the molecular layer of
the dentate gyrus, animals were injected with ibotenic
acid into the lateral EC, perfused with fixative, the brain
sectioned, and immunostained for brevican. Brevican is a
marker expressed by reactive glia in response to brain
injury [24]. Thus, after lesion, increased deposition of
brevican would be expected in the ipsilateral EC. Brevican
immunoreactivity was elevated at the lesion site (Figure
4B) compared to the contralateral, non-lesioned EC (Fig-
ure 4A).
Since an endpoint in this experiment is the reinnervation
and sprouting of neurites and the formation of new syn-
apses in the OML of the dentate gyrus, synaptophysin
immunoreactivity, a vesicular pre-synaptic marker, was
examined two, seven, and thirty days post-lesion. On the
contralateral side and in unlesioned mice, a tri-laminar
synaptophysin staining pattern was observed that outlines
the inner, middle and OMLs (Fig. 5B) of the dentate gyrus.
Two days after ECL, there was a marked decline in synap-
tophysin immunoreactivity in the OML on the ipsilateral
side of the dentate (Fig. 5A), that was reflected by a loss of
the typical tri-laminar pattern of synaptophysin staining
(Fig. 5B) with only the inner molecular layer clearly dis-
tinguishable. Seven days after ECL, synaptophysin immu-
noreactivity in the OML remained markedly reduced,
although the pattern was similar to the contralateral side
at 30 days (data not shown).
In response to injury and the deafferentation of synapses,
there is an activation of astrocytes in the OML [25]. Tissue
immunostained with the astrocytic marker GFAP (glial
fibrillary astrocytic protein), showed increased staining
selectively in the OML of the dentate seven days after ECL
(Fig. 5C) compared to the contralateral side (Fig. 5D).
Although these markers may be sufficient to identify some
level of diminished innervation to the OML, a synapto-
physin ELISA and a specific method to isolate the tissue of
the dentate gyrus (Fig. 1) was developed to better quanti-
tate this loss.
Two days after lesion, synaptophysin levels as detected by
ELISA, declined by 46% in the ipsilateral dentate com-
pared to the contralateral side (p = 0.039) (Fig. 5E). This
trend was sustained at seven days post-lesion, and synap-
tophysin levels were 41% of the contralateral value (p =
0.033) (Fig. 5E). However, when tissue was examined
thirty days post-lesion, synaptophysin concentrations
were not different from the control side. This observation
shows there is a complete reinnervation of the OML after
ECL (Fig. 5E).
The decline in the level of synaptophysin concentrations
in the tissue from the "dentate punch" on the ipsilateral
side compared to the contralateral side indicates that there
was denervation of cortical input to the dentate molecular
layer. The question of interest was, however, were there
Schematic representation of brevican cleavage by the  glutamyl-endopepidases, the ADAMTSs Figure 2
Schematic representation of brevican cleavage by 
the glutamyl-endopepidases, the ADAMTSs: A: 
Secreted brevican core protein that bears chondroitin sulfate 
chains (MW > 145 kD). B: Secreted brevican core protein 
without chondroitin sulfate side chains (MW = 145 kD). C: 
When cleaved by extracellular glutamyl endopeptidases, the 
ADAMTSs, an N-terminal fragment of brevican (MW = 55 
kD) is formed that contains the unique C-terminal epitope 
EAMESE. The anti-brevican antibody recognizes all three iso-
forms of brevican, whereas anti-EAMESE antibody selectively 
recognizes the ADAMTS-derived proteolytic fragment of 
brevican and not the parent protein or other isoforms.BMC Neuroscience 2005, 6:52 http://www.biomedcentral.com/1471-2202/6/52
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associated changes in the abundance and proteolysis of
brevican in this region of neural plasticity?
Abundance and proteolysis of brevican after ECL
Brevican and its various isoforms were identified in
immunoblots from isolated dentate gyrus tissue obtained
from mice two, seven and thirty days after ECL. At two
days post-lesion (Figure 6A), there was a 3-fold increase in
the glycosaminoglycan (GAG)-containing form of brevi-
can (p = 0.047) in the dentate on the denervated side, and
a trend for an increase in all the isoforms of brevican on
this side. At seven days after insult, a time thought to be
the initial synaptic reorganization period after ECL [26],
intact brevican had returned to contralateral levels, but
there was a significant, almost 2-fold elevation in the
ADAMTS-derived fragment of brevican in the dentate (p =
0.030). In addition, there was a trend for an increase in
the generalized 55 kD fragment of brevican (Fig. 6B) at
this time point. Thirty days after undergoing surgery, all of
the forms of brevican had returned to levels not different
from the contralateral side; however, a slight increase in
the GAG-containing, intact isoform was seen at this time
point (Fig. 6C).
To estimate apparent ADAMTS activity in vivo, the density
of the EAMESE (55 kD) immunoreactive fragment in
Western blot was divided by the densitometric level of
intact full-length and core protein brevican isoforms
(>145 kD + 145 kD) (Fig. 7). Two days post-ECL there was
a decrease in apparent ADAMTS activity in the ipsilateral
dentate gyrus, however, at the seven day critical
reinnervation period, ADAMTS activity was increased
almost 50%. This observation is supported by the signifi-
cant increase in the ADAMTS-derived, 55 kD fragment at
this time point. By thirty days post-lesion, the activity was
not different from the contralateral side. Thus, this data
suggests that the ADAMTSs and the catabolism of brevi-
can may play a prominent role in neural plasticity in the
dentate gyrus after lesion of the EC in mice.
Brevican and EAMESE Western blotting in regions of mouse brain Figure 3
Brevican and EAMESE Western blotting in regions of mouse brain: Panel A shows an immunoblot containing 
extracts from various regions of mouse brain and probed with anti-brevican antibody. Immunoreactive bands are present at 
>145 kD (high molecular weight smear), 145 kD core protein, and the generalized 55 kD fragment. Panel B contains a mem-
brane with the same samples probed with anti-EAMESE. This antibody recognized the specific ADAMTS-derived 55 kD frag-
ment of brevican. CB = cerebellum, BS = brain stem, DE = diencephalon, HC = hippocampus, FC = frontal cortex, TL = 
temporal lobe, and OT = olfactory tubercle.
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Discussion
The purpose of this study was to determine whether the
catabolism of brevican is involved in mechanisms of neu-
ral plasticity in the hippocampus, and to accomplish this,
synaptic input to the OML of the dentate gyrus was dener-
vated by excitotoxic lesion in the lateral EC. Two days after
lesion, synaptic input into the OML was significantly
reduced and this was accompanied by an increase in the
production of full length, intact brevican. At seven days,
while brevican levels returned to baseline, a significant
increase in the ADAMTS-derived, C-terminally truncated,
brevican fragment was observed during this initial,
sprouting and reinnervation period. This implies that
there was an increase in ADAMTS activity in the OML dur-
ing the highly plastic, regenerative phase. However at
thirty days post-lesion, there was complete reinnervation
of the OML on the ipsilateral side, as synaptic density,
brevican and ADAMTS activity were not different from the
contralateral side at this time point. These results indicate
that the ADAMTSs and their substrate, brevican, that is
abundant in the CNS, have a regulatory function in neural
plasticity and support earlier data that had demonstrated
important actions for the ADAMTSs in plasticity after sei-
zure-induced hippocampal lesion [16].
Previous studies have examined the role of matrix-altering
proteases in synaptic plasticity after CNS lesion. The
expression of the matrix metalloproteinases (MMPs),
MMP-9 and MMP-2, have been shown to be increased in
various regions of the hippocampus after seizure-induced
lesion [21,23,27,28]. MMP-3 concentrations were ele-
vated in the molecular layer of the dentate after traumatic
brain injury [29]. More specifically after ECL, administra-
tion of a non-selective MMP inhibitor was able to dimin-
ish sprouting and synaptogenesis in the dentate OML
[22], suggesting a direct proteolytic role for the MMPs in
this process. In adults, most MMP expression and activity
is low and maintained throughout adulthood. After injury
and during the recovery and regenerative phase, however,
there is increased activity of MMPs derived from glia and
neurons that is thought to facilitate axonal reinnervation,
sprouting and/or synaptogenesis. Nonetheless, the mech-
anism(s) of action of the MMPs and the potential
substrates on which they act to promote neural plasticity
have yet to be determined in these models. More recently,
the activity and expression of the PG-degrading,
ADAMTSs have been shown to be elevated in the OML
after kainite-induced lesion. In contrast to the absence of
a defined substrate for the MMPs, a selective ADAMTS-
Alterations in brevican levels in lesioned entorhinal cortex Figure 4
Alterations in brevican levels in lesioned entorhinal cortex: Horizontal sections of entorhinal cortex immunostained 
with anti-brevican antibody collected two days after entorhinal cortex lesion. A: Contralateral entorhinal cortex showed little 
immunoreactive signal. B: Ipsilateral entorhinal cortex showed abundant anti-brevican staining in the lateral region.
A BBMC Neuroscience 2005, 6:52 http://www.biomedcentral.com/1471-2202/6/52
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derived, brevican fragment was localized to the OML after
seizure-induced lesion in the rat [16]. In the present study,
a similar ADAMTS-derived brevican fragment was local-
ized to the OML of the mouse after discrete denervation of
the perforant path, suggesting a critical role in neural plas-
ticity for the proteolytic turnover of brevican. Thus, the
ability to localize and quantitate the ADAMTS specific,
proteolytic product of brevican provides a means to indi-
rectly estimate ADAMTS activity during times of neural
plasticity and synaptogenesis.
The expression of brevican was shown previously to be
up-regulated in the OML, the area of denervation after
ECL in the rat [10], however, in contrast to the transient
production observed here in the mouse, expression of
immunoreactive brevican remained elevated compared to
the non-lesioned side for almost 6 months after injury.
Neurocan is a lectican that is expressed at high levels dur-
ing early development but it was found to be up-regulated
and synthesized by astrocytes in the OML after ECL. It was
suggested that neurocan and possibly brevican may act to
maintain the boundary of the denervated dentate after
ECL [30], yet these complex molecules may be multifunc-
tional during periods of neural plasticity. Each of the lec-
ticans, exhibit a characteristic pattern of expression during
development, with neurocan and versican V1 highly
expressed in the brain of the fetus and neonate, whereas
aggrecan, versican V2 and brevican increase expression
during the period of synaptic stabilization in the adult
and expression remains high throughout adulthood
[13,31]. Each of the lecticans is thought to bind to
tenascin R and hyaluronic acid (with varying affinities)
forming a multi-molecular lattice of ECM [14]. It may be
that proteolytic cleavage of the lectican loosens the lattice
to promote neurite growth and synaptogenesis. Classi-
cally, the highly negatively charged CS chains on the lecti-
cans inhibits neurite outgrowth, but proteolytic cleavage
of the core protein may allow more movement of these
chains and actually promote plasticity of neurons. This is
a testable notion and preliminary data indicates that the
ADAMTSs promote neurite outgrowth and other meas-
ures of neural plasticity in vitro (our unpublished
observations).
The projection from the EC to the hippocampus is called
the perforant path [32], and is thought to be involved in
long-term potentiation and learning and memory [33-
35]. The ECL model to study neural and synaptic plasticity
denervates up to 80% of the input to the outer two-thirds
of the molecular layer of the dentate gyrus [36], and due
to sprouting of surviving fiber systems will reinnervate
nearly fully. This model was developed more than thirty
years ago in the rat [37], yet it has been only relatively
recently that the technique was employed in mice to take
advantage of transgenic models [38,39]. Surprisingly,
Denervation of the outer molecular layer of the dentate  gyrus after entorhinal cortex lesion Figure 5
Denervation of the outer molecular layer of the den-
tate gyrus after entorhinal cortex lesion: A and B: Syn-
aptophysin immunoreactivity in the molecular layer of the 
dentate gyrus two days after ECL A: ipsilateral dentate, B: 
contralateral dentate. Note diminished immunostaining and 
loss of tri-laminar pattern in the OML after ECL. C and D: 
GFAP immunoreactivity in the molecular layer of the dentate 
gyrus seven days after ECL. Note increased astroglial expres-
sion of GFAP observed after deafferentation of the ipsilateral 
(C), but not contralateral (D), OML. E: Synaptophysin levels 
in extracts from fresh micro-dissected (needle punch, see 
Fig. 1) dentate gyrus tissue as measured by ELISA. Synapto-
physin immunoreactivity was reduced two and seven days 
post-lesion. The ipsilateral side was not different from con-
tralateral dentate thirty days after lesion. oml = outer molec-
ular layer, mml = middle molecular layer, iml = inner 
molecular layer, and gcl = granule cell layer.
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there are some differences in the projections from the EC
to the hippocampal formation between rats and mice
[40]. For example, input to the dentate molecular layer
from the contralateral EC is absent in the mouse, yet these
contralateral fibers are responsible for much of the sprout-
ing after ECL in the rat. In addition, the width of the inner
molecular layer, that contains associational-commissural
fibers, is thinner in the mouse than in the rat, causing an
increase in the relative width occupied by the middle and
OMLs, layers innervated mainly by EC fibers. In the
mouse, the middle and OML occupy closer to four-fifths
of the total, rather than two-thirds as seen in the rat. More-
over, three layers can be clearly differentiated in an
untreated mouse, but not in a rat, using synaptophysin
immunohistochemistry [40], and following ECL this lam-
inar feature is lost (Fig. 5B). Synaptophysin immuno-
chemistry has been one of the more common techniques,
among many, to quantitate the loss and reinnervation of
input into the ipsilateral molecular layer of the dentate
gyrus after unilateral ECL [41]. Optical density of the syn-
aptophysin signal in the contralateral OML is measured
using the sum (or average) of the gray levels of the pixels
in this region, and this value is used as a "normal" value
to the ipsilateral side. However, with this technique, the
ipsilateral dentate usually shows only a 10–30% reduc-
tion in signal compared to the contralateral side at seven
days after lesion, a time when sprouting has begun [42].
Clearly this absolute value does not reflect the extent to
which fibers are actually lost in the OML after ECL. Thus,
we decided to develop a fresh tissue, needle punch dissec-
tion technique that could be limited to the dentate gyrus
in the mouse. This way, biochemical assays could be con-
ducted on the tissue to measure overall synaptophysin
immunoreactivity by ELISA. Using this method, at two
and seven days after lesion, there was greater than a 40%
reduction in synaptophysin levels in the OML, a value
which at least may closer reflect the absolute loss of fibers
after ECL. The major disadvantage of this method is that
the dissected tissue also includes the granule layer and the
hilus of the dentate, regions where input is not lost after
Brevican immunoreactivity in the dentate gyrus after entorhinal cortex lesion Figure 6
Brevican immunoreactivity in the dentate gyrus after entorhinal cortex lesion: Brevican immunoreactivity in the 
contralateral (CL) and ipsilateral (IL) dentate gyrus of mice that had undergone ECL two, seven, and thirty days earlier. Optical 
density was measured on the Western blots and data from the ipsilateral side was expressed as a fraction of the contralateral 
dentate. A: At two days, the CS-containing, >145 kD brevican was significantly elevated on the lesion side compared to the 
contralateral side although all fragments showed a trend for increase. B: At seven days, there was a significant elevation of the 
ADAMTS-derived EAMESE fragment of brevican and a trend for an increase in 55 kD fragment. C: At thirty days, brevican iso-
forms were not different from the control side, except that the >145 kD core protein was slightly elevated.
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ECL. At the same time using this technique, tissue con-
taining the lesion itself may be collected and assayed bio-
chemically or processed for histochemistry to monitor the
extent of the lesion in the EC.
The present results suggest that the lecticans and the pro-
teases that cleave the lecticans play a regulatory role in
neural plasticity after ECL. There are several potential
mechanisms by which this substrate – protease pair may
modulate neural plasticity, one of which was described
above. Significant changes were observed in the abun-
dance of the different isoforms of brevican including the
expression of the C-terminally-truncated ADAMTS-
derived brevican fragment during plastic events in the hip-
pocampus. A genetic approach to study the individual lec-
ticans and ADAMTSs could reveal the individual
contributions for each of the molecules involved in neural
plasticity after ECL, however, there is considerable redun-
dancy among these molecules. For example, there appears
to be a compensatory increase in the expression of neuro-
can in the brain of the brevican null mouse. [43] In addi-
tion, several of the ADAMTSs exhibit proteoglycanase
activity, and of these, at least ADAMTS1, 4 and 9 appear to
be expressed in the nervous system (unpublished observa-
tions). Whether there are compensatory changes in the
expression of any of these molecules in the brain in
ADAMTS null mice remains to be determined. Nonethe-
less, significant protective effects toward arthritic changes
were demonstrated just recently in a single mutant, the
ADAMTS5 null mouse [44]. Should it turn out that these
proteases play a significant role in plasticity related mech-
anisms in the nervous system, it will be interesting to
examine how removing this regulatory action will impact
development, sprouting after lesion, learning and mem-
ory and other plasticity related mechanisms in the adult.
Conclusion
Growth, sprouting and targeting in neural plasticity of an
ECL model may involve extracellular cues whose expres-
sion and/or secretion is altered following the lesion. One
of these cues is the extracellular PG, brevican. Here we
have demonstrated changes in brevican expression and
turnover after ECL that are associated with the loss and
time-dependent reinnervation of the OML of the dentate
gyrus.
Methods
Animals
All animal procedures described here were approved by
the Institutional Animal Care and Use Committee at the
University of South Florida. Sixty-two adult male C57Bl6
mice (23 g – 27 g; Harlan, Indianapolis, IN), 12 weeks of
age were housed under a 12 h light cycle with regulated
temperature and humidity. Mice were housed 3 to 4 per
cage and had free access to food and water. Following ECL
surgery, the animals were housed individually. Brains
from control mice (n = 4) and lesioned mice surviving for
2 days (n = 6), 7 days (n = 5) and 30 days (n = 5) after the
lesion were perfusion fixed and collected for immunohis-
tochemistry. Tissue extracts of dentate gyrus and EC
lesioned animals collected 2 days (n = 6), 7 days (n = 5)
and 30 days (n = 6) after surgery were used in Western blot
and biochemical immunoassays. For those animals that
received a unilateral ECL, the contralateral, non-lesioned
hemisphere was considered the control for immunohisto-
chemistry and biochemical analysis.
Surgical procedures – the entorhinal cortex lesion (ECL)
Surgeries were performed using isofluorane/oxygen
mixed gas anesthesia. Once deeply anesthetized, animals
were placed into the stereotaxic apparatus. A hole was
drilled in the skull of the right hemisphere to allow for
needle penetration. The right, lateral EC of mice was uni-
laterally lesioned by lowering a needle attached to a Ham-
ilton syringe (#701N) filled with ibotenic acid through
the hole in the skull to the coordinates AP = 4.72 mm, L =
Apparent ADAMTS activity Figure 7
Apparent ADAMTS activity: Apparent activity in the 
dentate gyrus of mice after entorhinal cortex lesion as meas-
ured by the ratio of the optical density of the ADAMTS-
derived EAMESE fragment and the sum of the densities of the 
brevican core protein isoforms (>145 kD + 145 kD). Mean 
level of apparent activity was calculated at two, seven and 
thirty days after lesion. At two days after lesion, ADAMTS 
activity declined, whereas at seven days a significant 47% 
increase in ADAMTS activity was observed compared to the 
contralateral ADAMTS activity. Levels on the lesioned side 
were not different from the non-lesioned dentate in tissue 
collected thirty days after lesion.
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3.75 mm and DV = 4.70 mm using bregma as a reference
and oriented 17° rostral-caudal [45]. One µl of the neuro-
toxin, ibotenic acid was injected into the lateral EC at a
rate of 0.1 µl every 30 seconds, with the needle remaining
in place for an additional minute at the end of the 5 min
injection period to allow for complete diffusion of the
drug into the lateral EC. Neurons of the lateral EC project
preferentially to the septal dentate gyrus. The needle was
removed, bone wax used to cover the skull hole, and the
animal was allowed to recover on a heating pad after
which the animal was returned to a new cage and housed
individually. At 2, 7 and 30 days after lesion, mice were
injected with an overdose of Nembutal (pentobarbital)
for deep anesthesia, perfused transcardially with cold
phosphate-buffered saline (pH 7.4) followed by cold 4%
paraformaldehyde fixative diluted in 0.1 M phosphate
buffer (pH 7.4). The brain was dissected from the skull,
post-fixed in 4% paraformaldehyde overnight at 4°C, cry-
oprotected with consecutive solutions of 15 and 30%
sucrose until completely infused, and the cryoprotected
brain was sectioned on a cryostat at 30 µm. The extent and
magnitude of the lesion in the EC was verified by cresyl
violet and brevican staining. Synaptophysin and GFAP
immunohistochemistry, using horseradish peroxidase
amplification and diaminobenzidine as a chromogen,
verified the loss of terminals in the molecular layer of the
dentate gyrus.
Region isolation method
A method was developed to isolate dentate gyrus and EC
tissue in mouse brain. This method eliminates the collec-
tion of much of the surrounding tissue that was unaf-
fected by ECL. The dentate gyrus was subjected to
synaptophysin ELISA as a measure of synaptic loss in the
molecular layer. The EC underwent Western blot for PSD
(post-synaptic density) 95 to quantitate the magnitude of
the lesion. In addition, brevican and EAMESE Western
blot was conducted on dentate gyrus tissue. Animals were
completely anesthetized with a lethal dose of Nembutal
(pentobarbital, Abbott Laboratories, North Chicago, IL),
the brain was quickly removed and placed on a glass
microscope slide, and a mm ruler was placed adjacent to
the brain to assist in measuring the thickness of slices.
Whole brain was dissected and frozen on a flat slab of dry
ice for about 5 minutes (a point at which the brain surface
is no longer shiny), being careful not to over-freeze the tis-
sue, but to reach a temperature at which the tissue can be
easily and efficiently cut into 2 mm coronal slabs. Two 2
mm coronal slabs are cut by referencing the most caudal
of cerebral cortex as a land mark, making a coronal cut,
moving rostrally 2 mm and making another cut to obtain
the first slab for the EC isolation. A third cut was made 2
mm rostral from the previous slice and this slab contained
the septal hippocampus and was used to isolate the den-
tate gyrus. The 2 mm hippocampal slab (outlined in Fig.
1C) was placed on a glass slide, and the dentate gyrus was
localized using a stereomicroscope. The dentate was punc-
tured with a blunt-ended 22 gauge needle (Fig. 1A) using
the medial point of the wings as a landmark. A blunt-
ended 18 gauge needle was used in the same manner to
puncture and collect the EC from a 2 mm slab caudal to
the slab used to collect the dentate gyrus (Fig. 1B). The fro-
zen tissues were immediately expelled from the needle by
attaching an air-loaded syringe to the needle and forcing
the tissue into the bottom of a microfuge tube. The den-
tate gyrus and EC tissues were then homogenized in
extraction buffer (20 nM Tris-HCL pH = 7.4, 5 mM EDTA,
1% Triton-X-100, & 1:100 protease inhibitor; 20 µl for
dentate gyrus and 40 µl for EC) using three cycles of 2 min
of 4°C incubation and 30 sec of vortex. The solubilized
extract was centrifuged at 8000 rpm in a refrigerated
microfuge for 3 min, the supernatant collected and frozen
for later use in Western blotting and ELISA analysis.
Immunohistochemistry
Mice were anesthetized with an overdose of Nembutal
(pentobarbital, Abbott Laboratories, North Chicago, IL)
and their brains were fixed via standard cardiac perfusion
methods. Briefly, the animal was cleared with phosphate
buffered saline (PBS; pH 7.4) and fixed with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB; pH
7.4). The brains were post-fixed overnight in the same fix-
ative; cryoprotected with 15% sucrose (in 0.1 M PB) fol-
lowed by a 30% sucrose solution for 24 h each. Whole
brain was frozen with mounting medium and cut into 30
µm coronal sections using a cryostat. Free-floating sec-
tions were washed with PBS, placed in a blocking/perme-
abilization solution (10% normal goat serum; 3% 1 M
Lysine, 3% Triton-X) for 1 h, washed with PBS and incu-
bated with primary antibody overnight at 4°C. For detec-
tion of the antigen, sections were washed and incubated
in secondary antibody solution (anti-rabbit or anti-mouse
IgG conjugated to Alexa-Fluor 488 or 594, Molecular
Probes, Eugene, OR) for 1 h. The sections were washed for
15 minutes, wet mounted onto Fisher SuperFrost Plus
glass sides and coverslipped with VectaShield mounting
medium (Vector Labs, Burlingame, CA).
The primary antibodies or probes used in these experi-
ments were: mouse anti-brevican, raised against the G1
domain of brevican (BD Transduction Labs, San Jose,
CA); rabbit anti-EAMESE, the ADAMTS-derived
neoepitope of brevican developed in our lab; rabbit anti-
glial fibrillary acidic protein (GFAP, DAKO, Carpinteria,
CA); and rabbit anti-synaptophysin (DAKO).
Western blotting
Dentate gryus or EC extracts were loaded (equal amounts
of protein and 2 × sample buffer) on to 4–20% polyacry-
lamide gels (Invitrogen, Carlsbad, CA) and subjected toBMC Neuroscience 2005, 6:52 http://www.biomedcentral.com/1471-2202/6/52
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SDS-PAGE. Protein was transferred to a polyvinylidine
difluoride membrane (PVDF, Immobilon, Millipore, Bill-
erica, MA) and the membrane was blocked with 5% milk
in PBS. Membranes were probed with primary antibodies
against brevican (1:1000), EAM (1:500), and secondary
anti-rabbit or anti-mouse IgG conjugated to horse radish
peroxidase (Chemicon, Temecula, CA). Antigens were vis-
ualized using a chemiluminescence developing system
(SuperSignal, Pierce, Rockford, IL).
Antibody generation
A rabbit antibody raised against the brevican neoepitope
on the 55 kD N-terminal fragment derived from glutamyl
endopeptidase activity of the ADAMTSs was generated by
Sigma-Genosys (St. Louis, MO) and purified in our labo-
ratory. The novel C-terminal sequence "QEAMESE" from
the mouse was the neoepitope and the peptide used for
antibody generation contained a glycine spacer
"GGGQEAMESE". This peptide was synthesized by
Sigma-Genosys, conjugated to keyhole limpet hemocy-
anin at the N-terminus, and rabbits were subjected to
standard immunization protocols. Serum collected after
the 5th booster was titered against the peptide using a
solid-phase system and specific antibody was purified
using peptide affinity chromatography. Interestingly, anti-
body raised against the rat epitope "QEAVESE" did not
recognize the mouse, ADAMTS-derived, "QEAMESE"
epitope. On Western blot, the antibody against the mouse
fragment recognized a single band at 55 kD in extracts
from mouse brain and did not cross react with the intact
brevican core protein.
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